Crossmark

CBX2 promotes cisplatin resistance in ovarian cancer via SIAH2-mediated β-catenin stabilization and ATG9B-dependent autophagy activation

Published Online: 2026-01-06

Authors

Kou, Xinxin

Dong, Lijie

Zhao, Zheng

Yang, Xiaoxia

Hu, Yuanjing
License Information

Text and Data Mining valid from 2026-01-06

Version of Record valid from 2026-02-17
More Information

Article History

Received: 18 July 2025

Accepted: 12 December 2025

First Online: 6 January 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current